|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 241.41 CNY | -0.17% |
|
+3.12% | -5.99% |
| 11-19 | APT Medical Subsidiary Gets China Approval for Tumor Oxygen Starvation Particles Device | MT |
| 10-27 | APT Medical's Attributable Profit Jumps 6.8% in Q3 | MT |
Business description: APT Medical Inc.
Number of employees: 2,555
Sales by Activity: APT Medical Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Medical Products | 479M | 829M | 1.22B | 1.65B | 2.07B |
Geographical breakdown of sales: APT Medical Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
China | 419M | 744M | 1.07B | 1.41B | 1.77B |
Overseas | 58.51M | 78.82M | 136M | 234M | 280M |
Executive Committee: APT Medical Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Zheng Hui Cheng
CEO | Chief Executive Officer | 61 | 31/07/2016 |
Zhen Hua Dai
DFI | Director of Finance/CFO | 57 | 08/11/2019 |
Yu Chen Qiu
CTO | Chief Tech/Sci/R&D Officer | 60 | 31/12/2010 |
Ya Chao Jiang
PRN | Corporate Officer/Principal | 39 | 31/03/2015 |
Yi Qing Xu
PRN | Corporate Officer/Principal | 62 | 30/09/2006 |
Composition of the Board of Directors: APT Medical Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Zheng Hui Cheng
CHM | Chairman | 61 | 30/04/2014 |
Yi Qing Xu
BRD | Director/Board Member | 62 | 30/04/2014 |
Zhen Hua Dai
BRD | Director/Board Member | 57 | 30/06/2013 |
Li Jun Xia
BRD | Director/Board Member | 49 | 08/11/2019 |
Yuan Xiang Zhu
BRD | Director/Board Member | 62 | 08/11/2019 |
Yue Feng Xiao
BRD | Director/Board Member | 62 | 08/11/2019 |
Lei Gong
CHM | Chairman | 41 | 08/11/2019 |
Ya Chao Jiang
BRD | Director/Board Member | 39 | 08/11/2019 |
Guang Rong Dai
BRD | Director/Board Member | 38 | 08/11/2019 |
Jing Xu
BRD | Director/Board Member | 45 | 20/11/2022 |
Company details: APT Medical Inc.

Medical Equipment
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.17% | +3.12% | -8.84% | +74.99% | 4.82B | ||
| -0.01% | +0.01% | +0.01% | +43.87% | 12.57B | ||
| +2.02% | +2.55% | +26.74% | +39.19% | 11.77B | ||
| -0.41% | -0.53% | -16.56% | +2.19% | 7.61B | ||
| +0.24% | -1.72% | +23.33% | -11.22% | 6.11B | ||
| -0.03% | +4.60% | +16.12% | +23.83% | 5.23B | ||
| -0.14% | +1.23% | +6.67% | +2.64% | 5.1B | ||
| +0.05% | -.--% | +56.56% | +14.67% | 4.7B | ||
| -1.00% | -5.18% | +54.01% | -12.40% | 2.01B | ||
| +1.23% | -0.82% | +0.10% | -48.71% | 1.62B | ||
| Average | +0.18% | -0.17% | +15.81% | +12.90% | 6.15B | |
| Weighted average by Cap. | +0.33% | +0.42% | +12.70% | +23.15% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Annual profits - Rate of surprise
- Stock Market
- Equities
- 688617 Stock
- Company APT Medical Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















